United Therapeutics Corporation Stock Forecast
On Wednesday, United Therapeutics Corporation stock price gained an impressive 8.88%
(Updated on May 01, 2024)
The United Therapeutics Corporation stock price gained 8.88% on the last trading day (Wednesday, 1st May 2024), rising from $234.33 to $255.14. During the last trading day the stock fluctuated 9.22% from a day low at $236.65 to a day high of $258.48. The price has risen in 6 of the last 10 days and is up by 8.43% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 686 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $329.49 million.
The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 10.75% during the next 3 months and, with a 90% probability hold a price between $263.04 and $293.10 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
UTHR Signals & Forecast
The United Therapeutics Corporation stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $238.43 and $236.64. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, April 01, 2024, and so far it has risen 11.78%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.
Support, Risk & Stop-loss for United Therapeutics Corporation stock
On the downside, the stock finds support just below today's level from accumulated volume at $235.78 and $229.72. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, United Therapeutics Corporation finds support just below today's level at $235.78. If this is broken, then the next support from accumulated volume will be at $229.72 and $228.26.
In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $21.83 between high and low, or 9.22%. For the last week the stock has had daily average volatility of 3.41%.
Our recommended stop-loss: $241.85 (-5.21%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 22 days ago.)
Trading Expectations (UTHR) For The Upcoming Trading Day Of Thursday 2nd
For the upcoming trading day on Thursday, 2nd we expect United Therapeutics Corporation to open at $250.09, and during the day (based on 14 day Average True Range), to move between $248.02 and $262.26, which gives a possible trading interval of +/-$7.12 (+/-2.79%) up or down from last closing price. If United Therapeutics Corporation takes out the full calculated possible swing range there will be an estimated 5.58% move between the lowest and the highest trading price during the day.
With no resistance above and support from accumulated volume @ $235.78, some $19.36 (7.59%) from the current price of $255.14, our system finds the risk reward attractive.
Earnings coming up
United Therapeutics Corporation will release earnings BMO on Wednesday, May 01, 2024.The consensus among the analysts for the expected earnings (EPS) is $5.63. We will update the financials statements for United Therapeutics Corporation, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 7.84% in the first trading day after earnings release.
Is United Therapeutics Corporation stock A Buy?
United Therapeutics Corporation holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.
Current score: 0.000 Hold/Accumulate Upgraded
Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.
Predicted Opening Price for United Therapeutics Corporation of Thursday, May 2, 2024
| Fair opening price May 2, 2024 | Current price |
|---|---|
| $250.09 ( 1.98%) | $255.14 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for UTHR
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 271.92 | 6.58 % | |
| R2 | 263.58 | 3.31 % | ||
| R1 | 258.43 | 1.29 % | ||
| Current price: | 255.14 | |||
| Support | S1 | 241.75 | -5.25 % | |
| S2 | 236.60 | -7.27 % | ||
| S3 | 228.26 | -10.54 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0 | . | |
| R2 | 0 | . | ||
| R1 | 0 | . | ||
| Current price | 255.14 | |||
| Support | S1 | 235.78 | -7.59% | |
| S2 | 229.72 | -9.96% | ||
| S3 | 228.26 | -10.54% |
FAQ
Click here for our free guide on how to buy United Therapeutics Corporation Stock.
